Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
Conditions: OAG - Open-Angle Glaucoma; OHT - Ocular Hypertension Interventions: Drug: Latanoprostene bunod 0.024% QD; Drug: Timolol maleate 0.5% BID Sponsors: University of California, San Diego; Bausch & Lomb Incorporated Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2019 Category: Research Source Type: clinical trials
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
Condition: Infantile Hemangioma Intervention: Drug: Timolol Maleate 0.5% Oph Soln Sponsor: XiaoXi Lin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials